FDA Updates List Of Drug Samples Generics Say Brands Are Withholding

By Beth Wang
February 8, 2019 at 2:09 PM
FDA on Friday (Feb. 8) updated its public list of brand drugs for which generic drug makers complain they can’t get a hold of the samples needed for generic development. The list update comes just days after HHS Secretary Alex Azar vowed to “pursue every avenue” to bring brand drug makers’ gaming tactics to an end, citing data that showed Medicare and Medicaid spend billions on brand drugs included on the list. The updated version of the list first published...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.